Transplant Diagnostics Market to Surpass US$ 17.2 Bn by 2035 with CAGR of 7.3% Fueled by Organ Transplant Surge and Technological Innovations

The global transplant diagnostics market was valued at US$ 7.8 Bn in 2024 and is projected to reach US$ 17.2 Bn by 2035, expanding at a CAGR of 7.3% from 2025 to 2035, according to a comprehensive market study by Transparency Market Research. The surge in organ transplant procedures, growing awareness of organ donation, and rapid technological advancements in molecular diagnostics and genetic testing are major factors accelerating market growth.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20225

Analysts' Viewpoint

The transplant diagnostics industry is undergoing a fundamental transformation powered by cutting-edge technologies like next-generation sequencing (NGS), machine learning, and circulating cell-free DNA (cfDNA) monitoring. Rising incidence of chronic diseases, aging populations, and supportive government policies worldwide are contributing to the growing demand for advanced diagnostic systems that ensure precise donor-recipient compatibility and improve transplant success rates.

Innovations in molecular assay techniques, along with the surge in organ donation campaigns, have further propelled industry growth. Leading players are investing in AI-integrated diagnostic solutions, creating a robust ecosystem for precision transplant care.

Market Overview

Transplant diagnostics encompasses a suite of technologies used to assess donor-recipient compatibility, detect immune responses, and monitor post-transplant health. These tools are essential for organ, tissue, and stem cell transplants, ensuring optimal matching and minimizing the risk of rejection.

HLA typing, genomic profiling, and biomarker identification are integral techniques that support the decision-making process before and after transplantation. Innovations in non-invasive diagnostics, such as cfDNA tests, enable continuous monitoring of graft health without biopsies.

Key Market Drivers

Rising Incidence of Organ Transplants

The number of global organ transplant procedures is steadily rising. In the U.S. alone, 48,149 organ transplants were performed in 2024-a 3.3% increase from the previous year. With increasing incidence of organ failure due to chronic conditions like kidney disease, liver cirrhosis, and cardiac disorders, demand for transplant-compatible diagnostics is at an all-time high.

Advanced technologies are being rapidly integrated into hospital labs and transplant centers to ensure better organ matching and post-operative success.

Growing Awareness and Acceptance of Organ Donation

Public and private campaigns have significantly raised awareness about organ donation, leading to an expanding donor pool. Initiatives led by government agencies, NGOs, and health influencers have normalized conversations about organ donation and fostered a cultural shift. This surge in donor availability requires precise diagnostics to ensure transplant suitability, boosting demand for molecular and immunological testing kits.

Digital health tools and social media platforms are amplifying organ donation campaigns and encouraging real-time testimonials from transplant recipients, further fueling market awareness.

Segment Insights

By Product & Service

Kits & Reagents dominate the market due to their integral role in HLA typing and antibody detection. Their widespread usage in hospitals and research labs makes them the backbone of transplant diagnostics.
Instruments and Software & Services are growing steadily as automation and AI integration become standard in diagnostic workflows.

By Technique

Molecular Assays lead the segment with advanced platforms like PCR and NGS, offering highly sensitive results and detailed genetic information crucial for transplant matching.

Non-Molecular Assays, including serological tests, remain important for basic screening but are increasingly complemented by molecular technologies.

By Transplant Type

Organ Transplants (Kidney, Liver, Heart, Lung) account for the largest share, driven by rising chronic illnesses and the availability of high-end diagnostic tools.

Tissue Transplants (Corneal, Skin, Bone) and Stem Cell Transplants are growing areas with increased research and clinical focus.

By Screening Type

Pre-transplant Diagnostics dominate due to the criticality of donor-recipient matching before procedures.

Post-transplant Diagnostics are gaining traction with innovations like cfDNA-based graft monitoring and early rejection detection tools.

Regional Outlook

North America led the transplant diagnostics market in 2024, accounting for the largest revenue share. Key factors include:

Advanced healthcare infrastructure
Strong presence of top diagnostics companies
Government support for organ donation programs
Higher prevalence of chronic and end-stage diseases

The U.S. dominates regional growth with robust transplant networks, strict regulatory oversight, and rapid adoption of AI-enabled diagnostics.

Asia Pacific is anticipated to witness the fastest CAGR through 2035 due to:

Rising awareness and transplant programs in India and China
Government initiatives to promote healthcare access
Emerging private-sector investments in medical diagnostics

Competitive Landscape

Leading players are expanding their product portfolios, engaging in strategic partnerships, and advancing automation to offer comprehensive transplant testing platforms.

Key Players

Abbott
Thermo Fisher Scientific, Inc.
QIAGEN N.V.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
Becton, Dickinson and Company
Illumina, Inc.
Siemens Healthineers
bioMérieux
Bruker Corporation
Agilent Technologies, Inc.
Hologic, Inc.
Takara Bio Inc.
Werfen, S.A.
DiaSorin S.p.A.
QuidelOrtho Corporation

Recent Developments

October 2024 - QIAGEN upgraded its EZ2 Connect platform for non-invasive liquid biopsy in transplant, oncology, and prenatal diagnostics, allowing high-throughput sample processing and precision ccfDNA isolation.
July 2024 - Thermo Fisher Scientific launched a CLIA-certified pre-transplant risk assessment assay, aimed at predicting acute rejection in kidney transplant patients, enabling tailored immunosuppressive therapy post-surgery.

Market Segmentation

By Product & Service

Instruments
Kits and Reagents
Software and Services

By Technique

Molecular Assay
Non-molecular Assay

By Transplant Type

Organ Transplant (Kidney, Liver, Heart, Lung, Others)
Tissue Transplant (Corneal, Skin, Bone, Cartilage, Others)
Stem Cell Transplant

By Screening Type

Pre-Transplant Diagnostics
Post-Transplant Diagnostics

By End-user

Hospitals
Transplant Centers
Research Laboratories
Others

Buy this Premium Research Report:

https://www.transparencymarketresearch.com/checkout.php?rep_id=20225<ype=S

Explore Latest Research Reports by Transparency Market Research:

Vaginal Pessaries Market- https://www.transparencymarketresearch.com/vaginal-pessaries-market-report.html

Drug-device Combination Products Market- https://www.transparencymarketresearch.com/drug-device-combination.html

U.S., Europe, and Japan Adhesion Barriers Market- https://www.transparencymarketresearch.com/u.s-europe-and-japan-adhesion-barriers-market.html

Atraumatic Needles Market- https://www.transparencymarketresearch.com/atraumatic-needles-market.html

Shoulder Replacement Market- https://www.transparencymarketresearch.com/shoulder-replacement-market.html

Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.